Wang X - Search Results

1

What do we know about the mechanisms of aromatase inhibitor resistance?

Chen S, Masri S, Wang X, Phung S, Yuan YC, Wu X. Chen S, et al. Among authors: wang x. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):232-40. doi: 10.1016/j.jsbmb.2006.09.012. Epub 2006 Oct 19. J Steroid Biochem Mol Biol. 2006. PMID: 17055257 Free PMC article. Review.

2

Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.

Wang X, Chen S. Wang X, et al. Cancer Res. 2006 Nov 1;66(21):10281-6. doi: 10.1158/0008-5472.CAN-06-2134. Cancer Res. 2006. PMID: 17079446

3

New experimental models for aromatase inhibitor resistance.

Chen S, Masri S, Hong Y, Wang X, Phung S, Yuan YC, Wu X. Chen S, et al. Among authors: wang x. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):8-15. doi: 10.1016/j.jsbmb.2007.05.020. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17611102 Free PMC article. Review.

4

The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.

Wang X, Masri S, Phung S, Chen S. Wang X, et al. Cancer Res. 2008 Apr 1;68(7):2259-65. doi: 10.1158/0008-5472.CAN-07-5544. Cancer Res. 2008. PMID: 18381432 Free PMC article.

5

Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.

Masri S, Phung S, Wang X, Wu X, Yuan YC, Wagman L, Chen S. Masri S, et al. Among authors: wang x. Cancer Res. 2008 Jun 15;68(12):4910-8. doi: 10.1158/0008-5472.CAN-08-0303. Cancer Res. 2008. PMID: 18559539

6

Characterization of the weak estrogen receptor alpha agonistic activity of exemestane.

Masri S, Lui K, Phung S, Ye J, Zhou D, Wang X, Chen S. Masri S, et al. Among authors: wang x. Breast Cancer Res Treat. 2009 Aug;116(3):461-70. doi: 10.1007/s10549-008-0151-x. Epub 2008 Aug 3. Breast Cancer Res Treat. 2009. PMID: 18677558 Free PMC article.

7

Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.

Masri S, Phung S, Wang X, Chen S. Masri S, et al. Among authors: wang x. J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):277-82. doi: 10.1016/j.jsbmb.2009.10.011. Epub 2009 Nov 6. J Steroid Biochem Mol Biol. 2010. PMID: 19897035 Free PMC article.

8

AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies.

Wong C, Wang X, Smith D, Reddy K, Chen S. Wong C, et al. Among authors: wang x. Breast Cancer Res Treat. 2012 Jul;134(2):671-81. doi: 10.1007/s10549-012-2105-6. Epub 2012 Jun 16. Breast Cancer Res Treat. 2012. PMID: 22706627 Free PMC article.

9

Selective targeting of TET catalytic domain promotes somatic cell reprogramming.

Singh AK, Zhao B, Liu X, Wang X, Li H, Qin H, Wu X, Ma Y, Horne D, Yu X. Singh AK, et al. Among authors: wang x. Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3621-3626. doi: 10.1073/pnas.1910702117. Epub 2020 Feb 5. Proc Natl Acad Sci U S A. 2020. PMID: 32024762 Free PMC article.

10

RNA 2'-O-methylation promotes persistent R-loop formation and AID-mediated IgH class switch recombination.

Kassab MA, Chen Y, Wang X, He B, Brown EJ, Yu X. Kassab MA, et al. Among authors: wang x. BMC Biol. 2024 Jul 8;22(1):151. doi: 10.1186/s12915-024-01947-5. BMC Biol. 2024. PMID: 38977974 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,574 results

Search Page

Filters